Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Public ClinicalTrials.gov record NCT04774159. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk: A Randomized Trial
Study identification
- NCT ID
- NCT04774159
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Population Health Research Institute
- Other
- Enrollment
- 6,150 participants
Conditions and interventions
Interventions
- Colchicine 0.5 MG Oral Tablet Drug
- Colchicine-Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 5, 2021
- Primary completion
- Nov 30, 2029
- Completion
- Nov 30, 2029
- Last update posted
- Mar 23, 2026
2021 – 2029
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yale School of Medicine | New Haven | Connecticut | 06511 | Recruiting |
| University of Florida - Gainesville | Gainesville | Florida | 32611 | Recruiting |
| Tampa General Hospital | Tampa | Florida | 33606 | Recruiting |
| University of Chicago Medical Center | Chicago | Illinois | 60615 | Recruiting |
| Henry Ford Health System | Detroit | Michigan | 48202 | Recruiting |
| Mayo Clinic | Rochester | Minnesota | 55905 | Recruiting |
| Rutgers University | Newark | New Jersey | 07103 | Recruiting |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | Recruiting |
| Duke Regional Hospital | Durham | North Carolina | 27704 | Recruiting |
| Duke University Medical Center | Durham | North Carolina | 27710 | Recruiting |
| Duke Raleigh Hospital | Raleigh | North Carolina | 27609 | Recruiting |
| Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | Recruiting |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Recruiting |
| Southwest Family Medicine | Dallas | Texas | 75235 | Recruiting |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | Recruiting |
| Texas Tech University Health Sciences | Lubbock | Texas | 79430 | Recruiting |
| Sentara Norfolk General Hospital | Norfolk | Virginia | 23507 | Recruiting |
| University of Washington Medical Center | Seattle | Washington | 98195 | Recruiting |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04774159, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04774159 live on ClinicalTrials.gov.